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Abstract 
Objective: To compare the sonographic measurement of maternal subcutaneous and 
visceral adipose thickness between pregnant women with gestational diabetes mellitus 
(GDM) and patients with non-diabetic pregnancies. 
Methods: Adipose thickness was measured by transabdominal ultrasound in pregnant 
women attending our antenatal clinics at 24-28 weeks’ gestation. All patients underwent a 
75g oral glucose challenge as a diagnostic test for GDM.  
Results: The study population comprised 56 women with a positive glucose challenge test 
and 112 non-diabetic pregnancies. Measurements of subcutaneous and visceral adipose 
tissues were converted into multiples of the median (MoM), adjusted for gestational age. 
The mean subcutaneous thickness MoM in patients with GDM was significantly higher 
compared to non-diabetic pregnancies (1.31 vs 1.07; p=0.011). Similarly, the mean 
visceral thickness MoM was higher in women with a positive oral glucose tolerance test 
compared to controls (1.61 vs 1.06; p<0.001). Multivariate logistic regression analysis 
demonstrated that visceral adipose thickness, but not subcutaneous thickness, was 
significantly and independently associated with GDM (OR 34, 95%CI 9.5–122.2).  
Conclusions: Sonographic thickness of maternal visceral adipose tissue at 24-28 weeks’ 
gestation was higher in women with GDM compared to non-diabetic pregnancies, 
independently from other known risk factors associated with GDM. 
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Introduction  
In recent years, obesity has become a public health problem in the industrialized world 
due to its increasing prevalence [1] and the association with cardio-vascular and metabolic 
disorders [2]. Obesity in pregnancy is a well-known risk factor for several fetal and 
obstetric complications, such as miscarriage, stillbirth, preeclampsia, macrosomia and 
gestational diabetes mellitus (GDM) [3,4]. It has been demonstrated that a body mass 
index (BMI) > 35 kg/m2 is associated with a five-fold increase in the risk of developing 
GDM [5]. 
The body fat mass is distributed into two compartments: subcutaneous adipose tissue, 
which accounts for 85% of the total, and visceral adipose tissue, that represents the 
remaining 15% [6]. It has been shown that an excessive accumulation of adipose tissue 
into the visceral compartment is associated with an increased risk for metabolic disorders 
[7-10]. 
Some studies have investigated the measurement of maternal adipose compartments by 
ultrasound in patients with GDM, showing that an increased thickness of visceral adipose 
tissue in the first trimester of pregnancy was associated with subsequent development of 
metabolic disorders [11-14].  
The aim of this study was to examine the sonographic measurement of maternal 
subcutaneous and visceral adipose thickness in pregnant women with GDM and in non-
diabetic patients. 
 
Methods 
In this prospective case-control study we included women with a singleton pregnancy 
attending our Centre for routine antenatal visits at 24-28 weeks’ gestation and patients 
attending the diabetic clinic following the diagnosis of GDM. Cases of known pre-
pregnancy diabetes mellitus, GDM diagnosed in the first trimester (fasting plasma glucose 
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level > 92 mg/dl) [15], chronic drug therapy, previous epigastric surgery, fetal 
chromosomal and/or major structural abnormalities were excluded. In all pregnancies, 
gestational age was calculated based on the ultrasound measurement of crown-rump 
length before 14 weeks’ gestation [16]. 
In accordance with the International Association of Diabetes and Pregnancy Study Groups 
(IADPSG) recommendations [15], all women underwent a 75-g oral glucose tolerance test 
of for the diagnosis of GDM between 24 and 28 weeks’ gestation. The diagnosis of GDM 
was made using the IADPSG criteria as follows: fasting glucose ≥ 92 mg/dl or glucose 
levels ≥ 180 mg/dl after 60 minutes and/or ≥ 153 mg/dl after 120 minutes from glucose 
administration. For each woman with a positive oral glucose tolerance test, two cases with 
a negative test were enrolled as controls. 
In all cases, after informed consent, a transabdominal ultrasound (RAB 4-8 MHz probe, 
Voluson E8 Expert, GE Medical Systems, Milwaukee, WI, USA) examination was carried 
out to measure fetal biometry, assess amniotic fluid and Doppler flow velocity in the 
umbilical artery. Additionally, a mid-sagittal section of the upper maternal abdomen was 
obtained, ensuring that the minimum possible pressure was applied with the ultrasound 
transducer on the abdomen (Figure 1a) as previously described [17]. On each image, the 
following landmarks were identified: skin, subcutaneous tissue, linea alba, liver and 
xiphoid process. The subcutaneous adipose thickness was measured as the maximum 
vertical distance from the skin line to the anterior edge of the linea alba. The visceral 
adipose thickness was measured on the same image from the posterior edge of the linea 
alba to the anterior surface of the left lobe of the liver (Figure 1b).  
The measurements were undertaken off-line, on stored ultrasound images, by an operator 
(F.D.) who was not aware of any clinical information, including the results from the glucose 
challenge test. In 90 randomly selected cases, the measurements of subcutaneous and 
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visceral adipose thickness were carried out twice by the same operator (F.D.) and in 44 
cases independently by two operators (F.D., F.C.). 
Information on obstetric and neonatal outcomes were retrieved from the hospital records 
and entered into a computer database for analysis. Large for gestational age neonates 
were defined based on a birthweight at or above the 90th percentile. 
The study was approved by the Institutional Review Board of Fondazione IRCCS Ca’ 
Granda, Ospedale Maggiore Policlinico, Milan, Italy (reference n.2955). 
 
Statistical analysis 
The distribution of subcutaneous and visceral thickness was made Gaussian after 
logarithmic transformation. Multiple regression analysis was used to determine which 
factors, among maternal age, ethnicity, BMI, parity and gestational age, were significantly 
associated with subcutaneous and visceral thicknesses in non-diabetic pregnancies. In all 
regression models, stepwise forward algorithms were performed to select variables at a p-
value cut-off of 0.05. 
The subcutaneous and visceral thicknesses, expressed as multiples of the median (MoM) 
of the normal group, were compared between patients with GDM and non-diabetic 
pregnancies.   
The Student T-test and Pearson χ2-squared test were performed for univariate 
comparisons of continuous and categorical variables, respectively. The Bland-Altman 
analysis was used to compare the measurement agreement and bias for a single examiner 
and between two examiners [18]. 
Logistic regression analysis was used to determine the variables that were significantly 
associated GDM. Univariate analysis was carried out to examine the individual variables 
contributing to GDM by assessing their odds ratios and 95% confidence intervals. 
Subsequently, multivariate logistic regression analysis with backward stepwise elimination 
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was performed to determine which of these variables provide a significant independent 
contribution in the logistic model.  
The data were analyzed using the statistical package IBM SPSS 22.0 (New York, USA) 
and Excel for Windows 2010 (Microsoft Corp., Redmond, WA, USA). 
 
Results 
After exclusion of 8 patients with a first trimester plasma glucose level of > 92 mg/dl and 4 
women with known pre-pregnancy diabetes, measurements of subcutaneous and visceral 
adipose tissue were carried out in 173 cases. Of these, 5 patients were lost to follow-up, 
leaving a population of 56 women with a positive glucose challenge test and 112 non-
diabetic pregnancies for data analysis.  
The mean maternal age was 34.5 (SD 5.1) years and mean gestational age at ultrasound 
was 27.3 (SD 1.3) weeks. Mean subcutaneous and visceral adipose thicknesses in non-
diabetic women were 9.3 mm (SD 3.6) and 9.7 mm (SD 2.2), respectively. The respective 
values in patients with GDM were 10.7 mm (SD 4.8) and 10.1 mm (SD 3.0). Regression 
analysis showed a significant association of subcutaneous and visceral thicknesses with 
gestational age at measurement. The regression equations are reported below: 
Log (expected) subcutaneous adipose thickness = 1.774311 - (0.031241* 
gestational age); 
Log (expected) visceral adipose thickness = 1.518001 - (0.0215341* gestational 
age). 
After adjustment for gestational age, the mean subcutaneous thickness MoM in patients 
with GDM was significantly higher compared to non-diabetic pregnancies (1.31 vs 1.07; 
p=0.011). Similarly, the mean visceral thickness MoM was higher in women with a positive 
oral glucose tolerance test compared to controls (1.61 vs 1.06; p<0.001). 
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The mean difference and the 95% limits of agreement between paired measurements of 
subcutaneous and visceral thicknesses by the same observer were 0.092 mm (-2.166 to 
1.982) and 0.016 mm (-1.994 to 1.961), respectively. The values in paired measurements 
by two different observers were 0.328 mm (-3.218 to 3.874) and 0.237 mm (-1.970 to 
2.444), respectively. 
Comparisons in maternal demographic and obstetric characteristics between the two study 
groups are shown in Table 1. Univariate logistic regression analysis demonstrated that 
maternal age, family history of diabetes mellitus, BMI, sonographic subcutaneous and 
visceral adipose thicknesses were significantly associated with GDM. However, the 
contribution of subcutaneous thickness did not remain independently significant in the 
multivariate model (Table 2). 
 
Discussion 
The findings of this study show that sonographic thickness of maternal visceral adipose 
tissue at 24-28 weeks’ gestation was higher in women with GDM compared to non-diabetic 
pregnancies, independently from other known risk factors associated with GDM. 
Previous studies have assessed body fat distribution in the non-pregnant population using 
computed tomography and/or magnetic resonance imaging. Neeland et al. [9] examined 
732 patients with obesity and found an independent association between type 2 diabetes 
and the visceral fat mass, but not with subcutaneous adiposity or BMI. Similarly, Bray et al. 
[10] examined 1106 subjects and reported that the visceral adipose mass was 
independently associated with diabetes mellitus type 2, with no significant relationship 
between subcutaneous adipose tissue and glucose intolerance. Therefore, there is 
evidence that the visceral adipose tissue may be involved in the regulation of glucose 
metabolism and that excessive visceral adiposity is associated with increased insulin 
resistance. 
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Some studies investigated the relationship between glycemic status in pregnancy and 
sonographic thickness of maternal adipose tissue, mostly based on small groups of cases 
evaluated during the first trimester of pregnancy [11-14]. Bartha et al. [11] examined 30 
women at 11-14 weeks’ gestation and found a significant association between 
sonographic measurement of visceral adipose tissue and glycemia, insulinemia, and 
insulin sensitivity. Martin et al. [12] reported that a visceral adipose thickness above the 
upper quartile of the normal range in the first trimester of pregnancy was significantly more 
frequent in 6 cases that subsequently developed GDM compared to 56 controls. In 
another recent study carried out at 4-14 weeks’ gestation in 94 pregnant women, Gur et al. 
[13] showed that visceral adipose tissue, more than BMI, was associated with the risk of 
developing GDM, dyslipidemia, hypertension and insulin resistance. However, the study 
population comprised only patients with obesity, who are known to be at increased risk for 
such disorders, and included 16 cases with a diagnosis of GDM. To the best of our 
knowledge, this is the first study examining the differences in the sonographic 
measurement of maternal adipose compartments at the time of diagnosis of GDM, which 
is usually made at 24-28 weeks’ gestation, showing that visceral adipose thickness is 
higher in GDM patients compared to non-diabetic pregnancies. The main limitation of our 
study is the case-control design and therefore, larger screening studies should be carried 
out to confirm our findings. 
The lack of an independent association between subcutaneous adipose thickness and 
GDM in our study is consistent with previous findings in non-pregnant individuals in 
relation to type 2 diabetes [8,9]. In adults, most of the weight gain is determined by 
progressive accumulation of adipose tissue into the subcutaneous compartment, with 
consequent increase in the BMI. It has been previously shown that pregnant women with 
obesity have a significantly higher risk of developing GDM [4] and therefore, measurement 
of the BMI is the most practical and effective method of quantifying the subcutaneous 
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adipose mass. Traditional risk factors for the development of GDM are increased maternal 
age, family history of diabetes mellitus and high BMI, and our data are consistent with 
these findings (Table 1). The present study also showed that the association between 
visceral adipose thickness and GDM remained significant when other variables were taken 
into account in the multiple regression model (Table 2), suggesting that increased visceral 
adiposity may be an independent factor associated with GDM. We could not show any 
significant difference between the study groups in the rate of Asian ethnicity, previous 
pregnancy with GDM and previous macrosomic baby, which are also considered as risk 
factors for GDM, and the likely explanation is that the prevalence of these conditions in our 
population was very low in both groups (Table 1). 
Recent studies have shown that more than 70% of pregnant women that will develop GDM 
can be identified at 11-13 weeks’ gestation, by combining information from maternal 
history, biophysical and biochemical markers into specific screening algorithms [19-21]. 
Large prospective studies can evaluate whether the inclusion of the visceral adipose 
thickness, measured in the first trimester of pregnancy, may provide an additional 
contribution in early identification of women at risk of developing GDM. First trimester 
screening for GDM has the main advantage of selecting a high risk group of women who 
may benefit from early dietary intervention or preventive medications, once their efficacy 
has been demonstrated by randomized controlled trials, with the primary objective to 
reduce the prevalence of GDM and its related feto-maternal complications. 
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Table 1. Maternal demographic and maternal characteristics of the study groups 
Characteristics GDM (n=56) Controls (n=112) P-value 
  Maternal    
    Age (years) 36.8 (4.8) 33.4 (4.8) <0.001 
    Body Mass Index (Kg/m2) 26.8 (6) 24.7 (3.3) 0.018 
    Ethnicity   0.366 
      White 53 (94.6) 108 (96.4)  
      Black 1 (1.8) 0 (0)  
      Asian 2 (3.6) 4 (3.6)  
    Family history of diabetes 20 (35.7) 13 (11.6) <0.001 
    Previous gestational diabetes 4 (7.1) 2 (1.8) 0.096 
    Previous newborn >4000 g 2 (3.6) 2 (1.8) 0.407 
        
  Obstetric    
Gestational age at delivery (weeks) 39 (1.2) 39.1 (1.4) 0.131 
Birth weight (g) 3307 (456) 3264 (508) 0.592 
Birth weight percentile 50.4 (26.6) 45.7 (27.3) 0.288 
Large-for-gestational-age neonates 8 (14.3) 9 (8) 0.160 
Stillbirth 1 (1.8) 0 (0) 0.333 
 
Data are expressed as n (%) or mean (SD).
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Table 2. Logistic regression analysis to examine the relationship between gestational diabetes and maternal demographic and biophysical 
variables. 
 
 
 
 
 
 
OR = Odds Ratio; CI = Confidence Intervals 
 
 
Variable 
Univariate analysis Multivariate analysis 
OR 95% CI P-value OR 95% CI P-value 
Maternal age (years) 1.163 1.077 – 1.256 <0.001 1.164 1.053 – 1.286 0.003 
Family history of diabetes 4.231 1.909 – 9.375 <0.001 4.470 1.690 – 11.825 0.003 
Body Mass Index (Kg/m2) 1.115 1.028 – 1.210 0.009 1.172 1.062 – 1.295 0.002 
Subcutaneous adipose tissue (MoM) 1.537 0.623– 3.789 0.0351 - - - 
Visceral adipose tissue (MoM) 35.92 10.716– 120.41 <0.001 34.047 9.489 – 122.166 <0.001 
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Figure legend 
Figure 1. Images showing the correct placement of the ultrasound transducer on the maternal 
abdomen (a) and the measurement of subcutaneous and visceral adipose thickness (b). 
 
